ArticleNeuro-oncology2011

Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma.

Martin G McCabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.